StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value
$235.63−1.25 (-0.53%)

Close on Nov 20, 2026Market cap $33.14BP/E 21.5Yield 1.02%

ResMed Stock-Based Compensation Costs by Quarter

Stock-Based Compensation Costs ($M) ($M)

Periods

ResMed Stock-Based Compensation Costs: $29.5M in Q1 FY27, up 39.2% from a year earlier. That is the highest of the 69 quarters on record here.

Latest, Q1 FY27
29.5
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
+39.2%
21.2 in Q1 FY26
History
69 quarters
Since Q1 FY10
Sources
64
Documents cited below

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedStock-Based Compensation Costs ($M) ($M)Year on yearSource
Q1 FY27CQ3 2026Sep 30, 202629.5+39.2%–
Q4 FY26CQ2 2026Jun 30, 202627.5+10.9%ResMed SEC Filing (0000943819-26-000047) ↗
Q3 FY26CQ1 2026Mar 31, 202626.8+11.2%ResMed SEC Filing (0000943819-26-000025) ↗
Q2 FY26CQ4 2025Dec 31, 202528.9+27.9%ResMed SEC Filing (0000943819-26-000007) ↗
Q1 FY26CQ3 2025Sep 30, 202521.2+5.0%ResMed SEC Filing (0000943819-25-000090) ↗
Q4 FY25CQ2 2025Jun 30, 202524.8+15.9%ResMed SEC Filing (0000943819-25-000035) ↗
Q3 FY25CQ1 2025Mar 31, 202524.1+18.1%ResMed SEC Filing (0000943819-25-000008) ↗
Q2 FY25CQ4 2024Dec 31, 202422.6+14.1%ResMed SEC Filing (0000943819-25-000004) ↗
Q1 FY25CQ3 2024Sep 30, 202420.2+9.2%ResMed SEC Filing (0000943819-24-000027) ↗
Q4 FY24CQ2 2024Jun 30, 202421.4+7.5%ResMed SEC Filing (0000943819-24-000013) ↗
Q3 FY24CQ1 2024Mar 31, 202420.4+14.6%ResMed SEC Filing (0000943819-24-000008) ↗
Q2 FY24CQ4 2023Dec 31, 202319.8+20.0%ResMed SEC Filing (0000943819-24-000003) ↗
Q1 FY24CQ3 2023Sep 30, 202318.5+9.5%ResMed SEC Filing (0000943819-23-000029) ↗
Q4 FY23CQ2 2023Jun 30, 202319.9+24.4%ResMed SEC Filing (0000943819-23-000011) ↗
Q3 FY23CQ1 2023Mar 31, 202317.8+11.9%ResMed SEC Filing (0000943819-23-000008) ↗
Q2 FY23CQ4 2022Dec 31, 202216.5+2.5%ResMed SEC Filing (0000943819-23-000003) ↗

Cite this data

StockData. (2026). ResMed Stock-Based Compensation Costs ($M), quarterly Q1 FY10–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/db-cf-sbc

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?